NPC cases and matched laryngeal squamous cell carcinomas (LSCC) from the Head and Neck 5000 study were characterized for their IgA and IgG antibody levels against 13 EBV antigens in a Duplex assay design. The gene discussed is CD79A; the disease is nasopharyngeal carcinoma.